This study aims to investigate the potential of C1QTNF4 as an antiobesity and anti-inflammatory adipokine.<h4>Methods</h4>Forty-eight subjects, with or without obesity and diabetes mellitus (DM), were categorized into two groups based on their health condition. The gene discussed is C1QTNF4; the disease is obesity due to melanocortin 4 receptor deficiency.